Patient Power®
Get Email Alerts!
Health Topics
Chronic Lymphocytic Leukemia (CLL) Health Center
Health Center Home Audio Programs Videos Conference Coverage
  • ASH 2012
    • Partner Spotlight
    Search by Keyword:
    Search by Health Topic:
    View all Health Topics >
    12/19/11

    Update on Kinase Inhibitors for CLL: Where Are We Now?

    Kinase inhibitors, a newer approach to fighting blood cancers, have been making major strides throughout 2011 for the treatment of CLL.  Dr. Susan O'Brien, an investigator of this approach, gives us an update on the ongoing trials for CAL-101 and PCI-32765.  She explains how they are not only very effective at fighting the CLL and can be taken orally, but how kinase inhibitors carry lower toxicity which allows them to be better tolerated, especially by older patients. Additionally, these drugs do not cause myelosuppression--the reduction of desirable cells in the blood--that is associated with chemotherapy treatment.

    Get Email Updates:

    Get updated automatically when new content about Chronic Lymphocytic Leukemia has been posted.
    Privacy Policy
    Chronic Lymphocytic Leukemia

    Experts & Guests

    Susan M. O'Brien, MD Susan M. O'Brien, MD
    Professor, Department of Leukemia, Division of Cancer Medicine, MD Anderson Cancer Center
    Susan M. O’Brien, M.D., is a professor in the department of leukemia and clinical consultant and special assistant to the physician-in-chief at MD Anderson Cancer Center. Dr. O’Brien received her medical degree from the University of Medicine and Dentistry of New Jersey in Newark. She went on to complete a residency in internal medicine at the University of Medicine and Dentistry of... more >

    Transcript

    1. Update on Kinase Inhibitors for CLL: Where Are We Now?

    Related Videos

    Dr. Michael Keating, President of the CLL Global Research Foundation, gives an overview of treatment and research from the past year and looks forward to 2012

    Watch Now
    Dr. Steven Rosen, Director of the Lurie Cancer Center in Chicago, shares his perspective on the latest news from the American Society of Hematology's 2011 annual meeting, focused around major advances in Chronic Lymphocytic Leukemia (CLL)...

    Watch Now
    The CLL Global Alliance brings together the foremost experts in Chronic Lymphocytic Leukemia. Take an inside look at their work and preview our series of CLL video interviews for 2011.

    Watch Now